SCHEMBL285207

SCHEMBL285207

CCCCC(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6013339 1.00
SCHEMBL2226688 1.00
SCHEMBL15494036 0.92
SCHEMBL16565997 0.92
SCHEMBL997385 0.92
SCHEMBL25260863 0.90 OPRM1 (0.48)
SCHEMBL8604975 0.90 OPRM1 (0.48)
SCHEMBL3325909 0.90 OPRM1 (0.48)
SCHEMBL3322430 0.90 OPRM1 (0.48)
SCHEMBL13494822 0.90 OPRM1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110041327-A Pyridione derivatives, its composition and the application as anti-influenza virus medicament 银杏树药业(苏州)有限公司 2019-07-23 CN claimed
CN-208756568-U A kind of light power kit for rectal neoplasm treatment 中国医学科学院生物医学工程研究所 2019-04-19 CN claimed
CN-106977494-A Substituted pyrazolecarboxylic amides compound and its application 海利尔药业集团股份有限公司 2017-07-25 CN claimed
CN-106588870-A Substituted salicylamide compound and application thereof 海利尔药业集团股份有限公司 2017-04-26 CN claimed
US-9469645-B2 Compounds and compositions for the treatment of parasitic diseases NOVARTIS AG (CH) 2016-10-18 US claimed
EP-2737927-B1 Imidazo[1,2a]pyrazines and compositions comprising them for the treatment of parasitic diseases NOVARTIS AG (CH) 2016-03-30 EP claimed
CN-104220601-A Method for preparing 6-carbon chemicals via CoA-dependent carbon chain elongation associated with carbon storage INVISTA NORTH AMERICA SARL 2014-12-17 CN claimed
CN-102317464-B Biological Synthesis of Difunctional Alkanes from Carbohydrate Feedstocks CELEXION, LLC (US) 2014-10-29 CN claimed
CN-102471341-B Compounds and compositions for the treatment of parasitic diseases IRM LLC 2014-07-02 CN claimed
EP-2737927-A1 Imidazo[1,2a]pyrazines and compositions comprising them for the treatment of parasitic diseases IRM LLC (BM) 2014-06-04 EP claimed
US-20050261194-A1 Use of thymulin-like peptides for making pain-relieving medicines INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE ("I.N.S.E.R.M.") (FR) 2005-11-24 US claimed
EP-1450843-A2 USE OF THYMULIN-LIKE PEPTIDES FOR MAKING PAIN-RELIEVING MEDICINES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2004-09-01 EP claimed
CN-1454086-A High affinity small molecule C5A receptor modulators NEUROGEN CORP (US) 2003-11-05 CN claimed
WO-2003030927-A2 USE OF THYMULIN-LIKE PEPTIDES FOR MAKING PAIN-RELIEVING MEDICINES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M.) (FR) 2003-04-17 WO claimed
CN-1260779-A Epsilon-caprolactam composition and by products UNION CARBIDE CHEMICALS & PROD (US) 2000-07-19 CN claimed
EP-0866800-A2 ANTINEOPLASTIC PEPTIDES BASF AKTIENGESELLSCHAFT (DE) 1998-09-30 EP claimed
WO-1997022621-A2 ANTINEOPLASTIC PEPTIDES BASF AKTIENGESELLSCHAFT (DE) 1997-06-26 WO claimed
CN-1017900-B PROCESS FOR PRODUCTION OF ELLIPTICINE DERIVATIVE SUNTORY LTD (JP) 1992-08-19 CN claimed
US-4680276-A Metal polypeptides INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1987-07-14 US claimed
CN-85107911-A The production method of ellipticine derivative 1987-02-25 CN claimed